IVA

Conviction 12HealthcareScan · Thu, Sep 24, 2026

Inventiva S.A. (IVA) closed at $3.27 (-5.22%) on Sep 24, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 18, RS Rating 16, -54.3% from its 52-week high, -31.3% year to date. Sector: Healthcare · Biotechnology.

IVA$3.27-5.22%

ResistanceSupportVol 14

Vol MA14 1.76M

Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24

Inventiva S.A.Biotechnologywww.inventivapharma.com ↗

Price3.27

Change-5.22%

Gap-2.32%

Rel volume1.45×

Avg volume1.52M

Avg $ vol6.15M

SMA 204.19

SMA 504.44

SMA 2005.05

Price vs 50-26.42%

Price vs 200-35.24%

MA stackbearish

50/200 cross—

Supertrenddown · 3.99

RSI (14)18

MACD hist-0.10

MACD cross—

Stoch %K / %D9 / 8

ADX (14)30

+DI / −DI9 / 35

RSI divergence—

MACD divergence—

ATR %7.56%

ADR %5.96%

52w high7.15

52w low3.27

From 52w high-54.27%

Above 52w low+0.00%

New 52w highNo

SqueezeOff

Bollinger width50.45%

%B0.06

Donchian pos8.04%

Donchian high5.10

Donchian low3.11

AVWAP (52w high)4.61

vs AVWAP high-29.07%

AVWAP (52w low)3.25

vs AVWAP low+0.62%

OBV trendDown

Chaikin MF (20)0.02

Today vs 20d1.45×

Avg vol (14d)1.76M

Avg vol (20d)1.52M

Avg $ vol (20d)6.15M

Market cap631.88M

RS Rating16 / 99

RS 3m (vs SPY)-11.06%

RS 6m (vs SPY)-62.50%

RS line new highNo

Trend template1/8

Technical rank6.3

1 week-12.80%

1 month-30.28%

3 months-6.57%

6 months-45.68%

1 year-42.33%

YTD-31.30%

P/E—

P/B—

P/S—

P/FCF—

EPS—

Div yield—

ROE—

ROA—

Debt/Eq—

Current—

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth—

Price target16.25

Target upside396.94%

Analyst ratingBuy

Institutional36.82%

Ent. value631.88M

Revenue—

Net income—

Gross profit—

Free cash flow—

IndustryBiotechnology

ExchangeNasdaq

Shares out209.01M

Employees77

ListedFri, Jul 10, 2020

Free float157.92M

Float %66.9%

Short interest3.68M

Days to cover5.3d

Short volume47.6%

Squeeze score41 / 100

Next earningsFri, Sep 25, 2026 · after (1d)

EPS forecast−$0.20

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction12 / 100

Pattern quality—

Tech rank6.3 / 100

Group rank59 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance5.04

Support4.34

Days since event—

Candle confirm—

Congress activity

Disclosed STOCK Act trades in IVA

All disclosures →

No recent disclosed trades by Congress in IVA. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in IVA

No recent insider (Form 4) filings in IVA. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in IVA · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.